Cargando…
Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer.
The tumour-suppressor gene TP53 is frequently mutated in breast tumours, and the majority of the mutations are clustered within the core domain, the region involved in DNA binding. We searched for alterations in this central domain of the TP53gene in 222 human breast cancer specimens using polymeras...
Autores principales: | Berns, E. M., van Staveren, I. L., Look, M. P., Smid, M., Klijn, J. G., Foekens, J. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150115/ https://www.ncbi.nlm.nih.gov/pubmed/9569050 |
Ejemplares similares
-
Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2
por: Schuyer, M, et al.
Publicado: (2001) -
Infrequent CDKN2 (MTS1/p16) gene alterations in human primary breast cancer.
por: Berns, E. M., et al.
Publicado: (1995) -
Expression profiling of BRCA1 associated breast tumors
por: Berns, EMJJ, et al.
Publicado: (2000) -
Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?
por: Monti, Paola, et al.
Publicado: (2020) -
Sporadic CDKN2 (MTS1/p16ink4) gene alterations in human ovarian tumours.
por: Schuyer, M., et al.
Publicado: (1996)